The Inhibition Mechanisms of Three Structurally Different Salvianolic Acids on the Non-Enzymatic Glycation of Bovine Serum Albumin

Guo Feng1, Yu Yan1, Mengfan Wang1, Zhao Gao2, Yinan Zhao2, Xin Peng2,1,3
1School of Life Sciences, Tianjin University, Tianjin, PR China
2Key Laboratory of Biotechnology and Bioresources Utilization of Ministry of Education, Dalian Minzu University, Dalian, PR China
3State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Guangxi Normal University, Guilin, PR China

Tóm tắt

The antiglycation mechanisms of three structurally different salvianolic acids (Sals) including salvianolic acid A (Sal-A), salvianolic acid B (Sal-B) and salvianolic acid C (Sal-C) were investigated using the bovine serum albumin (BSA)-fructose model. The results showed that the three compounds could inhibit the formation of glycation products, maintain protein structural stability, mitigate the development of amyloid fibrils and scavenge radicals. Notably, Sal-A possessed the highest anti-glycated activity compared with Sal-B and Sal-C. This may be related to the fact that Sal-A contained the most molecules of caffeic acid (Sal-A, Sal-B, and Sal-C possessing two, one, and zero caffeic acid units, respectively), and caffeic acid played a leading role in the antiglycation properties relative to Danshensu. Moreover, these compounds quenched the intrinsic fluorescence intensity of BSA in a static mode, with the binding constants in the order of Sal-A > Sal-B > Sal-C. Obviously, Sal-A possessed the strongest binding affinity among these compounds, which may be one of the reasons why it exhibited the optimal antiglycation capability. Furthermore, molecular docking demonstrated that the three Sals exerted protective effects on BSA by preventing glycation modification of lysine and arginine residues. These findings would provide valuable insights into the potential application of Sals for alleviating non-enzymatic glycation of protein.

Từ khóa


Tài liệu tham khảo

Lapolla A, Traldi P, Fedele D (2005) Importance of measuring products of non-enzymatic glycation of proteins. Clin Biochem 38:103–115. https://doi.org/10.1016/j.clinbiochem.2004.09.007 Zhou Q, Cheng K, Xiao J et al (2020) The multifunctional roles of flavonoids against the formation of advanced glycation end products (AGEs) and AGEs-induced harmful effects. Trends Food Sci Tech 103:333–347. https://doi.org/10.1016/j.tifs.2020.06.002 Wang R, Khalifa I, Du X et al (2021) Effects of anthocyanins on β-lactoglobulin glycoxidation: a study of mechanisms and structure-activity relationship. Food Funct 12:10550–10562. https://doi.org/10.1039/d1fo01665b Haque A, Brazeau D, Amin AR (2021) Perspectives on natural compounds in chemoprevention and treatment of cancer: an update with new promising compounds. Eur J Cancer 149:165–183. https://doi.org/10.1016/j.ejca.2021.03.009 Ho JHC, Hong CY (2011) Salvianolic acids: small compounds with multiple mechanisms for cardiovascular protection. J Biomed Sci 18:30. https://doi.org/10.1186/1423-0127-18-30 Wu Q, Tang S, Zhang L et al (2020) The inhibitory effect of the catechin structure on advanced glycation end product formation in alcoholic media. Food Funct 11:5396–5408. https://doi.org/10.1039/c9fo02887k Ni M, Song X, Pan J et al (2021) Vitexin inhibits protein glycation through structural protection, methylglyoxal trapping, and alteration of glycation site. J Agric Food Chem 69:2462–2476. https://doi.org/10.1021/acs.jafc.0c08052 Lee EY, Lee BW, Kim D et al (2011) Glycated albumin is a useful glycation index for monitoring fluctuating and poorly controlled type 2 diabetic patients. Acta Diabetol 48:167–172. https://doi.org/10.1007/s00592-010-0242-0 Li X, Zheng T, Sang S et al (2014) Quercetin inhibits advanced glycation end product formation by trapping methylglyoxal and glyoxal. J Agric Food Chem 62:12152–12158. https://doi.org/10.1021/jf504132x Awasthi S, Saraswathi NT (2015) Silybin, a flavonolignan from milk thistle seeds, restrains the early and advanced glycation end product modification of albumin. RSC Adv 5:87660–87666. https://doi.org/10.1039/c5ra15550a Bharmoria P, Rao KS, Trivedi TJ et al (2014) Biamphiphilic ionic liquid induced folding alterations in the structure of bovine serum albumin in aqueous medium. J Phys Chem B 118:115–124. https://doi.org/10.1021/jp4102042 Shamsi A, Ahmed A, Khan MS et al (2020) Rosmarinic acid restrains protein glycation and aggregation in human serum albumin: Multi spectroscopic and microscopic insight-possible therapeutics targeting diseases. Int J Biol Macromol 161:187–193. https://doi.org/10.1016/j.ijbiomac.2020.06.048 Qais FA, Ahmad I (2019) Mechanism of non-enzymatic antiglycation action by coumarin: a biophysical study. New J Chem 43:12823–12835. https://doi.org/10.1039/C9NJ01490J Bouma B, Kroon-Batenburg LMJ, Wu YP et al (2003) Glycation induces formation of amyloid cross-β structure in albumin. J Biol Chem 278:41810–41819. https://doi.org/10.1074/jbc.m303925200 Zeng L, Zhang G, Liao Y et al (2016) Inhibitory mechanism of morin on α-glucosidase and its anti-glycation properties. Food Funct 7:3953–3963. https://doi.org/10.1039/c6fo00680a Frolov A, Blüher M, Hoffmann R (2014) Glycation sites of human plasma proteins are affected to different extents by hyperglycemic conditions in type 2 diabetes mellitus. Anal Bioanal Chem 406:5755–5763. https://doi.org/10.1007/s00216-014-8018-y Benvidi A, Rezaeinasab M, Gharaghani S et al (2018) Monitoring the protective ability of thymoquinone mixture with p-cymene against bovine serum albumin (BSA) glycation: MCR-ALS analysis based on combined spectroscopic and electrochemical methods. Int J Biol Macromol 107:2465–2474. https://doi.org/10.1016/j.ijbiomac.2017.10.135